The device was used for treatment.The device was discarded and not returned for analysis, therefore, the exact cause of the product issue cannot be determined and the clinical observation could not be confirmed.The lot number of this device was not provided, therefore neither a review of the device history record nor complaint history could be performed.Inspection procedures require any oscor product to pass all in-process and qa final inspections before shipping to the customer.However, the following controls are in place to mitigate the reported product issue.Per procedure adelante-s introducer sheath in process and final inspection, ensures sheaths are inspected for visual, dimensional, and peel functional compliance.Destructive testing sampling plan ansi z 1.4, special level 4, aql 0.40 reduced.Break and peel test: using samples from fit check, manually break the sheath and hub and verify that the seal splits easily without extreme elongation.Also verify that the split cap and seal remain secure and do not break free or loosen from the sheath hub.Manually peel the sheath and verify the sheath peels easily along the sheath body and tip.The instructions for use (ifu), adelante safesheath ii informs the user: sharply snap the tabs of valve housing in a plane perpendicular to the long axis of the sheath to split the valve and peel sheath apart while withdrawing from the vessel.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.In addition, there was no new failure mode identified and the risk remains acceptable.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.
|